,coef,coef_graph,coef_combined,coef_combined_zscore,coef_combined2
Selenoamino acid metabolism,9.682689e-06,8.0,9.682689e-06,-0.13746707,-0.8702105
Formation of xylulose-5-phosphate,9.076158e-06,2.0,9.076158e-06,-0.13772435,0.13538042
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,1.8189626e-08,2.0,1.8189626e-08,-0.14156649,0.13264568
Diseases associated with the TLR signaling cascade,1.4918289e-05,12.0,1.4918289e-05,-0.13524628,-1.5391457
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells,0.0,2.0,0.0,-0.1415742,0.1326402
Scavenging of heme from plasma,3.5688024e-07,2.0,3.5688024e-07,-0.14142284,0.13274793
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,0.00024005688,2.0,0.00024005688,-0.039748628,0.2051167
ABC transporter disorders,0.00012211078,16.0,0.00012211078,-0.08977814,-2.177299
mTORC1-mediated signalling,3.121343e-05,2.0,3.121343e-05,-0.12833433,0.14206396
Signaling by NOTCH1,0.0005797071,3.0,0.0005797071,0.10432173,0.14003286
Abacavir transmembrane transport,0.0,2.0,0.0,-0.1415742,0.1326402
Platelet calcium homeostasis,3.549309e-06,3.0,3.549309e-06,-0.1400687,-0.033917237
Signaling by NTRKs,0.00011264717,5.0,0.00011264717,-0.09379235,-0.33623707
Common Pathway of Fibrin Clot Formation,7.3755227e-06,2.0,7.3755227e-06,-0.1384457,0.13486697
Beta-catenin independent WNT signaling,0.00021194918,3.0,0.00021194918,-0.051671144,0.029001605
Signaling by VEGF,8.556764e-05,4.0,8.556764e-05,-0.105278745,-0.17678376
Reversal of alkylation damage by DNA dioxygenases,2.4442135e-09,3.0,2.4442135e-09,-0.14157318,-0.034988083
"Transport of bile salts and organic acids, metal ions and amine compounds",9.586591e-06,8.0,9.586591e-06,-0.13750783,-0.87023956
rRNA processing in the mitochondrion,5.2162577e-05,2.0,5.2162577e-05,-0.11944827,0.1483888
Signaling by Retinoic Acid,7.408101e-07,2.0,7.408101e-07,-0.14125997,0.13286385
RNA Polymerase I Chain Elongation,8.6260854e-08,2.0,8.6260854e-08,-0.14153762,0.13266623
Mitotic G1-G1/S phases,7.1723764e-07,4.0,7.1723764e-07,-0.14126998,-0.20240128
Signaling by BMP,9.25769e-06,2.0,9.25769e-06,-0.13764735,0.13543522
Oncogenic MAPK signaling,5.0336996e-05,7.0,5.0336996e-05,-0.12022263,-0.6903074
Digestion of dietary carbohydrate,8.827293e-06,2.0,8.827293e-06,-0.13782991,0.13530527
Assembly of collagen fibrils and other multimeric structures,1.2253142e-05,3.0,1.2253142e-05,-0.13637675,-0.03128942
Deubiquitination,0.0018134357,6.0,0.0018134357,0.6276357,0.009625775
Mitotic Spindle Checkpoint,2.784073e-07,3.0,2.784073e-07,-0.14145611,-0.034904763
Synthesis of IPs in the nucleus,3.5878568e-07,2.0,3.5878568e-07,-0.14142202,0.13274851
Diseases associated with surfactant metabolism,9.176133e-05,8.0,9.176133e-05,-0.10265156,-0.84542984
Transcriptional activation of mitochondrial biogenesis,1.595532e-05,2.0,1.595532e-05,-0.1348064,0.13745733
"Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism",1.9612264e-07,6.0,1.9612264e-07,-0.14149101,-0.53781664
DNA strand elongation,0.00022902309,4.0,0.00022902309,-0.04442886,-0.13347255
"BMAL1:CLOCK,NPAS2 activates circadian gene expression",6.137582e-06,2.0,6.137582e-06,-0.1389708,0.13449322
mRNA decay by 3' to 5' exoribonuclease,1.3129204e-07,2.0,1.3129204e-07,-0.14151852,0.13267982
Diseases associated with glycosylation precursor biosynthesis,0.0,16.0,0.0,-0.1415742,-2.2141657
Signaling by Interleukins,0.007080346,12.0,0.007080346,2.8617153,0.5940056
"TET1,2,3 and TDG demethylate DNA",9.804739e-06,2.0,9.804739e-06,-0.1374153,0.13560037
Degradation of beta-catenin by the destruction complex,1.8894902e-05,3.0,1.8894902e-05,-0.13355951,-0.029284181
Cellular response to hypoxia,0.0048865695,2.0,0.0048865695,1.9311752,1.6079639
Gap junction trafficking and regulation,0.00038983204,3.0,0.00038983204,0.023781914,0.08270692
Recognition of DNA damage by PCNA-containing replication complex,0.00022727452,2.0,0.00022727452,-0.045170553,0.20125754
Receptor Mediated Mitophagy,0.0034543986,2.0,0.0034543986,1.3236874,1.1755714
M Phase,2.8440763e-06,5.0,2.8440763e-06,-0.14036782,-0.36938816
Endosomal Sorting Complex Required For Transport (ESCRT),0.0017868058,2.0,0.0017868058,0.6163401,0.6721018
Signaling by NOTCH3,1.6060825e-06,3.0,1.6060825e-06,-0.14089294,-0.034503914
Defective Mismatch Repair Associated With MLH1,1.8464961e-07,2.0,1.8464961e-07,-0.14149588,0.13269594
"Synthesis of IP2, IP, and Ins in the cytosol",9.3574845e-06,2.0,9.3574845e-06,-0.13760501,0.13546534
Regulation of signaling by NODAL,2.7293261e-05,2.0,2.7293261e-05,-0.12999715,0.1408804
Neddylation,9.5152285e-07,2.0,9.5152285e-07,-0.14117059,0.13292746
Phenylketonuria,0.0,2.0,0.0,-0.1415742,0.1326402
Eukaryotic Translation Initiation,0.0012461419,3.0,0.0012461419,0.38700518,0.34123883
Caspase activation via extrinsic apoptotic signalling pathway,5.892108e-05,3.0,5.892108e-05,-0.11658149,-0.017199717
Fibronectin matrix formation,0.0,2.0,0.0,-0.1415742,0.1326402
Signaling by WNT in cancer,4.128389e-06,11.0,4.128389e-06,-0.13982306,-1.3747743
Transcription-Coupled Nucleotide Excision Repair (TC-NER),4.305141e-05,4.0,4.305141e-05,-0.12331297,-0.18962
Platelet Adhesion to exposed collagen,7.4566024e-06,2.0,7.4566024e-06,-0.13841131,0.13489145
O-linked glycosylation,3.601981e-05,3.0,3.601981e-05,-0.12629558,-0.024113936
eNOS activation and regulation,6.445671e-05,4.0,6.445671e-05,-0.11423343,-0.18315744
Signaling by Activin,1.0731039e-09,2.0,1.0731039e-09,-0.14157376,0.13264051
Signaling by ROBO receptors,1.5755239e-06,9.0,1.5755239e-06,-0.1409059,-1.0402873
G2/M Checkpoints,9.322348e-10,4.0,9.322348e-10,-0.14157382,-0.20261756
Post-transcriptional silencing by small RNAs,5.5703526e-06,2.0,5.5703526e-06,-0.13921142,0.13432196
Metabolism of water-soluble vitamins and cofactors,0.00033476457,11.0,0.00033476457,0.00042379324,-1.2749506
RIPK1-mediated regulated necrosis,6.520808e-08,2.0,6.520808e-08,-0.14154655,0.13265988
Defects in vitamin and cofactor metabolism,0.0017017067,3.0,0.0017017067,0.58024335,0.47878015
Signaling by PDGF,8.820901e-09,2.0,8.820901e-09,-0.14157046,0.13264285
Post-translational modification: synthesis of GPI-anchored proteins,8.488076e-06,4.0,8.488076e-06,-0.1379738,-0.20005517
TCF dependent signaling in response to WNT,9.148754e-05,10.0,9.148754e-05,-0.10276768,-1.1807704
TRAIL  signaling,6.566722e-05,2.0,6.566722e-05,-0.11371997,0.15246604
Pentose phosphate pathway,2.7881986e-06,2.0,2.7881986e-06,-0.14039153,0.13348198
Defective Mismatch Repair Associated With MSH2,1.5017135e-07,2.0,1.5017135e-07,-0.1415105,0.13268553
Positive epigenetic regulation of rRNA expression,0.0004104911,3.0,0.0004104911,0.032544926,0.08894418
SUMOylation,0.0014847564,3.0,0.0014847564,0.48821893,0.41327986
Miscellaneous transport and binding events,8.879052e-07,2.0,8.879052e-07,-0.14119758,0.13290825
Digestion of dietary lipid,1.5362986e-12,2.0,1.5362986e-12,-0.1415742,0.1326402
Mitochondrial transcription termination,3.0532916e-05,2.0,3.0532916e-05,-0.12862298,0.1418585
Listeria monocytogenes entry into host cells,0.00063583447,3.0,0.00063583447,0.12812944,0.1569785
tRNA processing in the nucleus,1.3118714e-08,2.0,1.3118714e-08,-0.14156865,0.13264415
Glycogen metabolism,0.00046400956,3.0,0.00046400956,0.05524599,0.10510216
mRNA Splicing,0.00025661866,3.0,0.00025661866,-0.03272357,0.04248794
Heme degradation,2.0046484e-05,2.0,2.0046484e-05,-0.13307104,0.1386925
Synaptic adhesion-like molecules,7.117488e-05,2.0,7.117488e-05,-0.111383766,0.15412888
Pyruvate metabolism and Citric Acid (TCA) cycle,2.3607732e-05,4.0,2.3607732e-05,-0.13156044,-0.19549032
Nitric oxide stimulates guanylate cyclase,5.1664152e-08,2.0,5.1664152e-08,-0.1415523,0.13265578
Biosynthesis of specialized proresolving mediators (SPMs),1.479427e-05,6.0,1.479427e-05,-0.13529888,-0.53340924
Signaling by ERBB2,2.9725854e-05,9.0,2.9725854e-05,-0.1289653,-1.0317882
"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation",4.2094067e-07,2.0,4.2094067e-07,-0.14139566,0.13276727
RNA Polymerase II Transcription Termination,2.200257e-05,2.0,2.200257e-05,-0.13224131,0.13928308
Pyrophosphate hydrolysis,3.685067e-11,2.0,3.685067e-11,-0.14157419,0.1326402
Phase 2 - plateau phase,1.4139081e-05,2.0,1.4139081e-05,-0.1355768,0.13690898
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),3.4174087e-07,2.0,3.4174087e-07,-0.14142925,0.13274337
Protein methylation,1.1475238e-07,2.0,1.1475238e-07,-0.14152554,0.13267483
Phase II - Conjugation of compounds,1.634798e-06,7.0,1.634798e-06,-0.14088078,-0.70501125
Transport of Mature Transcript to Cytoplasm,2.5624875e-05,3.0,2.5624875e-05,-0.13070484,-0.02725231
Neurotransmitter uptake and metabolism In glial cells,1.5654049e-06,2.0,1.5654049e-06,-0.14091021,0.13311282
Neutrophil degranulation,0.00011254347,2.0,0.00011254347,-0.09383634,0.16661865
Deadenylation of mRNA,2.0362886e-05,2.0,2.0362886e-05,-0.13293684,0.13878803
Asparagine N-linked glycosylation,1.9090963e-05,4.0,1.9090963e-05,-0.13347635,-0.196854
Growth hormone receptor signaling,0.0001105775,2.0,0.0001105775,-0.09467024,0.16602509
Striated Muscle Contraction,8.2104685e-05,2.0,8.2104685e-05,-0.106747635,0.15742874
HDACs deacetylate histones,1.7628763e-05,2.0,1.7628763e-05,-0.13409656,0.13796256
Cytosolic iron-sulfur cluster assembly,7.5802404e-08,2.0,7.5802404e-08,-0.14154205,0.13266309
Signaling by MST1,0.0,2.0,0.0,-0.1415742,0.1326402
Signaling by MET,2.4261559e-05,9.0,2.4261559e-05,-0.13128312,-1.033438
Signaling by Leptin,1.16054e-06,2.0,1.16054e-06,-0.14108193,0.13299057
Nucleobase catabolism,7.6074975e-05,4.0,7.6074975e-05,-0.10930528,-0.17964973
MTF1 activates gene expression,0.0001614094,2.0,0.0001614094,-0.07310874,0.18137196
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,1.2523493e-06,2.0,1.2523493e-06,-0.14104299,0.1330183
Hedgehog 'on' state,3.2315133e-05,4.0,3.2315133e-05,-0.127867,-0.19286142
Toll-Like Receptors Cascades,0.00016673189,10.0,0.00016673189,-0.07085109,-1.1580532
tRNA Aminoacylation,1.7914568e-05,3.0,1.7914568e-05,-0.13397533,-0.02958016
IP6 and IP7 transport between cytosol and nucleus,0.0,2.0,0.0,-0.1415742,0.1326402
Transcriptional regulation by small RNAs,0.0010490277,2.0,0.0010490277,0.3033947,0.4493563
Metabolism of Angiotensinogen to Angiotensins,5.302274e-07,2.0,5.302274e-07,-0.1413493,0.13280027
DAG and IP3 signaling,2.5038646e-05,2.0,2.5038646e-05,-0.1309535,0.1401997
Processing of SMDT1,2.7599554e-05,2.0,2.7599554e-05,-0.12986724,0.14097288
Scavenging by Class A Receptors,9.945458e-06,2.0,9.945458e-06,-0.13735563,0.13564287
Eukaryotic Translation Termination,0.00039575048,2.0,0.00039575048,0.026292354,0.2521228
Synthesis of pyrophosphates in the cytosol,9.2024413e-07,2.0,9.2024413e-07,-0.14118387,0.13291803
Smooth Muscle Contraction,0.0002192975,2.0,0.0002192975,-0.04855419,0.19884917
Aflatoxin activation and detoxification,1.7284856e-06,2.0,1.7284856e-06,-0.14084104,0.13316205
Intestinal hexose absorption,0.0,2.0,0.0,-0.1415742,0.1326402
Erythrocytes take up carbon dioxide and release oxygen,0.00039738553,2.0,0.00039738553,0.026985899,0.25261644
PECAM1 interactions,5.211713e-07,2.0,5.211713e-07,-0.14135315,0.13279752
AUF1 (hnRNP D0) binds and destabilizes mRNA,0.00033188687,2.0,0.00033188687,-0.0007968484,0.23284148
C-type lectin receptors (CLRs),5.4476153e-05,4.0,5.4476153e-05,-0.11846691,-0.18617071
Type I hemidesmosome assembly,1.3738433e-08,2.0,1.3738433e-08,-0.14156838,0.13264434
Clathrin-mediated endocytosis,2.7674523e-06,2.0,2.7674523e-06,-0.14040034,0.13347572
Apoptotic execution phase,3.9055626e-06,4.0,3.9055626e-06,-0.13991757,-0.20143868
IPs transport between nucleus and ER lumen,0.0,2.0,0.0,-0.1415742,0.1326402
Cargo trafficking to the periciliary membrane,2.1328826e-05,5.0,2.1328826e-05,-0.1325271,-0.36380738
Macroautophagy,2.9882234e-05,2.0,2.9882234e-05,-0.12889898,0.14166206
Formation of the cornified envelope,1.0714557e-05,2.0,1.0714557e-05,-0.1370294,0.13587506
IRE1alpha activates chaperones,3.9168012e-06,2.0,3.9168012e-06,-0.13991281,0.13382272
Scavenging by Class F Receptors,3.788774e-06,2.0,3.788774e-06,-0.13996711,0.13378407
IPs transport between cytosol and ER lumen,0.0,2.0,0.0,-0.1415742,0.1326402
Defective Mismatch Repair Associated With MSH6,7.591782e-09,2.0,7.591782e-09,-0.14157099,0.13264248
WNT ligand biogenesis and trafficking,1.07489406e-07,2.0,1.07489406e-07,-0.14152862,0.13267264
IPs transport between ER lumen and cytosol,0.0,2.0,0.0,-0.1415742,0.1326402
ESR-mediated signaling,5.720325e-05,2.0,5.720325e-05,-0.117310144,0.14991066
MAPK6/MAPK4 signaling,2.202749e-05,2.0,2.202749e-05,-0.13223074,0.1392906
Mitochondrial translation,0.0001960179,4.0,0.0001960179,-0.058428757,-0.14343728
GPCR ligand binding,1.544412e-05,4.0,1.544412e-05,-0.13502324,-0.19795503
"Incretin synthesis, secretion, and inactivation",0.0001286091,3.0,0.0001286091,-0.08702173,0.0038400695
Signaling by SCF-KIT,7.870171e-05,2.0,7.870171e-05,-0.10819109,0.15640134
Signaling by FGFR in disease,2.7247577e-05,5.0,2.7247577e-05,-0.13001652,-0.36202043
HATs acetylate histones,9.155763e-07,2.0,9.155763e-07,-0.14118585,0.13291661
Small interfering RNA (siRNA) biogenesis,9.77118e-05,2.0,9.77118e-05,-0.100127526,0.16214074
PERK regulates gene expression,9.192346e-06,2.0,9.192346e-06,-0.13767506,0.1354155
Signaling by NOTCH2,1.1279912e-05,3.0,1.1279912e-05,-0.13678958,-0.031583257
Interferon Signaling,0.00095694105,4.0,0.00095694105,0.26433408,0.086296044
RMTs methylate histone arginines,5.515165e-06,2.0,5.515165e-06,-0.13923483,0.1343053
Ion homeostasis,2.039375e-09,2.0,2.039375e-09,-0.14157334,0.13264081
Cell-extracellular matrix interactions,3.7638132e-05,3.0,3.7638132e-05,-0.12560914,-0.023625342
FasL/ CD95L signaling,1.5137624e-08,2.0,1.5137624e-08,-0.14156778,0.13264476
ER to Golgi Anterograde Transport,0.0028101131,4.0,0.0028101131,1.0503991,0.64579463
GPCR downstream signalling,0.00037995836,7.0,0.00037995836,0.01959377,-0.5907901
HCN channels,4.064345e-06,2.0,4.064345e-06,-0.13985021,0.13386728
Meiotic recombination,0.0010373354,2.0,0.0010373354,0.29843515,0.44582623
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,1.3741071e-07,2.0,1.3741071e-07,-0.14151593,0.13268167
Negative epigenetic regulation of rRNA expression,1.8942303e-05,3.0,1.8942303e-05,-0.1335394,-0.029269863
Energy dependent regulation of mTOR by LKB1-AMPK,9.056751e-06,2.0,9.056751e-06,-0.13773258,0.13537456
CREB3 factors activate genes,0.00012484091,2.0,0.00012484091,-0.0886201,0.17033142
IPs transport between nucleus and cytosol,0.0,2.0,0.0,-0.1415742,0.1326402
Melanin biosynthesis,0.0,2.0,0.0,-0.1415742,0.1326402
Fc epsilon receptor (FCERI) signaling,5.6335077e-05,5.0,5.6335077e-05,-0.11767841,-0.35323846
RNA Polymerase III Chain Elongation,1.2556175e-06,2.0,1.2556175e-06,-0.1410416,0.13301928
Scavenging by Class H Receptors,1.52063085e-05,2.0,1.52063085e-05,-0.1351241,0.13723119
RNA Pol II CTD phosphorylation and interaction with CE,8.752905e-05,2.0,8.752905e-05,-0.104446776,0.15906642
Semaphorin interactions,1.365324e-06,6.0,1.365324e-06,-0.14099507,-0.5374636
Collagen biosynthesis and modifying enzymes,8.8883844e-08,2.0,8.8883844e-08,-0.1415365,0.13266702
Intra-Golgi and retrograde Golgi-to-ER traffic,7.7525e-05,4.0,7.7525e-05,-0.10869021,-0.17921193
Heme biosynthesis,0.00083994825,2.0,0.00083994825,0.21470892,0.3862323
SLBP independent Processing of Histone Pre-mRNAs,7.8712205e-08,2.0,7.8712205e-08,-0.14154081,0.13266397
mRNA 3'-end processing,2.4966746e-06,2.0,2.4966746e-06,-0.1405152,0.13339396
"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",0.00047244804,3.0,0.00047244804,0.058825366,0.10764985
Phase 3 - rapid repolarisation,5.1208817e-06,2.0,5.1208817e-06,-0.13940208,0.13418625
Laminin interactions,3.3845809e-06,2.0,3.3845809e-06,-0.14013857,0.13366205
Response to elevated platelet cytosolic Ca2+,0.00013276332,3.0,0.00013276332,-0.085259624,0.0050942875
DNA Double Strand Break Response,1.124781e-05,3.0,1.124781e-05,-0.1368032,-0.03159294
tRNA processing in the mitochondrion,4.1443595e-06,2.0,4.1443595e-06,-0.13981628,0.13389142
Plasma lipoprotein remodeling,1.1629297e-06,5.0,1.1629297e-06,-0.14108092,-0.36989573
snRNP Assembly,3.2047848e-07,2.0,3.2047848e-07,-0.14143826,0.13273695
Passive transport by Aquaporins,3.0233443e-05,2.0,3.0233443e-05,-0.12875001,0.14176808
L1CAM interactions,6.1808566e-07,7.0,6.1808566e-07,-0.14131203,-0.7053182
Fanconi Anemia Pathway,3.6945483e-05,2.0,3.6945483e-05,-0.12590294,0.14379455
RORA activates gene expression,0.0014003686,2.0,0.0014003686,0.452424,0.55543107
Insulin processing,3.835327e-07,2.0,3.835327e-07,-0.14141153,0.132756
p75 NTR receptor-mediated signalling,1.6463317e-05,8.0,1.6463317e-05,-0.13459092,-0.8681634
Synthesis of IP3 and IP4 in the cytosol,0.00016617285,2.0,0.00016617285,-0.07108822,0.1828101
Protein ubiquitination,0.00020229744,3.0,0.00020229744,-0.055765152,0.026087606
CDO in myogenesis,5.637907e-05,2.0,5.637907e-05,-0.11765974,0.14966182
Glycosaminoglycan metabolism,0.00021224988,6.0,0.00021224988,-0.051543593,-0.4737946
Chaperonin-mediated protein folding,0.0038722558,4.0,0.0038722558,1.500931,0.96647036
Signaling by NOTCH1 in Cancer,0.00042195118,6.0,0.00042195118,0.037405975,-0.41048285
Scavenging by Class B Receptors,2.5040451e-08,2.0,2.5040451e-08,-0.1415636,0.13264774
Glyoxylate metabolism and glycine degradation,1.4720932e-08,2.0,1.4720932e-08,-0.14156796,0.13264464
Plasmalogen biosynthesis,3.438834e-08,2.0,3.438834e-08,-0.14155962,0.13265057
Signaling by EGFR,4.8665817e-05,6.0,4.8665817e-05,-0.12093149,-0.5231829
Generic Transcription Pathway,0.00076027034,11.0,0.00076027034,0.18091173,-1.1464845
Platelet sensitization by LDL,9.499106e-06,2.0,9.499106e-06,-0.13754494,0.1355081
Tandem pore domain potassium channels,2.4062254e-08,7.0,2.4062254e-08,-0.141564,-0.70549756
"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",6.342272e-07,4.0,6.342272e-07,-0.14130518,-0.20242634
Insulin effects increased synthesis of Xylulose-5-Phosphate,3.70713e-08,2.0,3.70713e-08,-0.14155848,0.13265139
Hedgehog 'off' state,0.0012108914,4.0,0.0012108914,0.3720529,0.16296722
Metabolic disorders of biological oxidation enzymes,0.00026759363,33.0,8.108897e-06,-0.13813463,-4.983069
Signaling by the B Cell Receptor (BCR),0.00013313374,4.0,0.00013313374,-0.085102506,-0.16242288
Defective Mismatch Repair Associated With MSH3,2.8265083e-08,2.0,2.8265083e-08,-0.14156222,0.13264872
Plasma lipoprotein clearance,0.00017735052,6.0,0.00017735052,-0.06634695,-0.48433122
Phase 4 - resting membrane potential,5.621982e-06,2.0,5.621982e-06,-0.13918951,0.13433754
RNA Polymerase II Pre-transcription Events,6.448805e-05,2.0,6.448805e-05,-0.11422014,0.15211004
Molecules associated with elastic fibres,0.00010798457,2.0,0.00010798457,-0.0957701,0.16524224
PRC2 methylates histones and DNA,0.0003709027,2.0,0.0003709027,0.015752606,0.24462089
tRNA modification in the mitochondrion,4.792273e-06,2.0,4.792273e-06,-0.13954146,0.13408704
Signaling by FGFR,3.6404504e-05,5.0,3.6404504e-05,-0.12613241,-0.35925585
EPH-Ephrin signaling,2.5222573e-07,5.0,2.5222573e-07,-0.14146723,-0.37017068
Transport of inorganic cations/anions and amino acids/oligopeptides,4.610025e-05,11.0,4.610025e-05,-0.122019745,-1.3621025
Galactose catabolism,6.1886844e-06,2.0,6.1886844e-06,-0.13894913,0.13450864
Threonine catabolism,6.286956e-07,2.0,6.286956e-07,-0.14130753,0.13283001
DNA replication initiation,3.4408422e-05,2.0,3.4408422e-05,-0.1269791,0.14302857
RNA Polymerase II Transcription Initiation And Promoter Clearance,4.701087e-05,3.0,4.701087e-05,-0.12163348,-0.020795578
PI3K/AKT Signaling in Cancer,0.00034620866,4.0,0.00034620866,0.005278065,-0.098092586
Extrinsic Pathway of Fibrin Clot Formation,0.0,2.0,0.0,-0.1415742,0.1326402
Reversible hydration of carbon dioxide,1.3058253e-08,2.0,1.3058253e-08,-0.14156866,0.13264413
Activation of PPARGC1A (PGC-1alpha) by phosphorylation,5.1457306e-08,2.0,5.1457306e-08,-0.14155237,0.13265572
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha),0.00031768178,2.0,0.00031768178,-0.006822258,0.22855276
Abacavir metabolism,1.0794368e-10,2.0,1.0794368e-10,-0.14157416,0.13264023
Triglyceride metabolism,1.8718834e-05,3.0,1.8718834e-05,-0.1336342,-0.029337337
Basigin interactions,2.1645046e-06,2.0,2.1645046e-06,-0.14065608,0.13329369
Vasopressin regulates renal water homeostasis via Aquaporins,2.9690686e-06,2.0,2.9690686e-06,-0.14031482,0.13353659
Global Genome Nucleotide Excision Repair (GG-NER),5.8222827e-07,5.0,5.8222827e-07,-0.14132725,-0.37007108
rRNA processing in the nucleus and cytosol,0.002581348,3.0,0.002581348,0.9533632,0.7443563
NR1D1 (REV-ERBA) represses gene expression,9.3254785e-06,2.0,9.3254785e-06,-0.13761859,0.13545568
Signaling by PTK6,9.696589e-07,10.0,9.696589e-07,-0.1411629,-1.208099
MHC class II antigen presentation,0.047371224,2.0,0.047371224,19.952007,14.434674
PKA-mediated phosphorylation of key metabolic factors,1.4467339e-12,2.0,1.4467339e-12,-0.1415742,0.1326402
Butyrophilin (BTN) family interactions,4.268283e-06,2.0,4.268283e-06,-0.13976371,0.13392884
Rho GTPase cycle,1.3584746e-07,2.0,1.3584746e-07,-0.14151658,0.1326812
Amino acid synthesis and interconversion (transamination),5.354804e-05,2.0,5.354804e-05,-0.11886059,0.1488071
Activation of anterior HOX genes in hindbrain development during early embryogenesis,0.00012906533,2.0,0.00012906533,-0.08682821,0.17160681
"Gamma carboxylation, hypusine formation and arylsulfatase activation",1.4202946e-06,5.0,1.4202946e-06,-0.14097175,-0.36981806
RNA Polymerase III Transcription Termination,1.8484481e-07,2.0,1.8484481e-07,-0.14149581,0.13269599
Tie2 Signaling,2.5590657e-07,2.0,2.5590657e-07,-0.14146565,0.13271746
Switching of origins to a post-replicative state,0.0007034838,3.0,0.0007034838,0.15682444,0.1774028
Rab regulation of trafficking,0.0019106049,3.0,0.0019106049,0.6688523,0.54184943
Uptake and actions of bacterial toxins,0.0009786701,5.0,0.0009786701,0.27355096,-0.07477265
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),0.0003949748,2.0,0.0003949748,0.025963334,0.2518886
Sulfur amino acid metabolism,5.2679314e-09,4.0,5.2679314e-09,-0.14157197,-0.20261623
Effects of PIP2 hydrolysis,3.0620622e-08,2.0,3.0620622e-08,-0.14156123,0.13264944
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,1.2618017e-07,2.0,1.2618017e-07,-0.14152068,0.13267829
Signaling by NOTCH4,2.2780268e-05,4.0,2.2780268e-05,-0.13191144,-0.19574013
PP2A-mediated dephosphorylation of key metabolic factors,1.7440495e-09,2.0,1.7440495e-09,-0.14157346,0.13264072
Dissolution of Fibrin Clot,6.6442944e-08,2.0,6.6442944e-08,-0.14154603,0.13266025
Signaling by EGFR in Cancer,5.7190697e-05,4.0,5.7190697e-05,-0.11731548,-0.18535115
MGMT-mediated DNA damage reversal,1.0537984e-07,2.0,1.0537984e-07,-0.1415295,0.13267201
Regulation of gene expression in early pancreatic precursor cells,0.0,2.0,0.0,-0.1415742,0.1326402
RET signaling,1.2506154e-06,2.0,1.2506154e-06,-0.14104372,0.13301778
Signaling by Insulin receptor,0.00044707075,3.0,0.00044707075,0.048061013,0.099988095
Peptide hormone biosynthesis,0.0,2.0,0.0,-0.1415742,0.1326402
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),0.0011567659,2.0,0.0011567659,0.34909433,0.48188394
RNA Polymerase II Transcription Elongation,1.8688275e-05,3.0,1.8688275e-05,-0.13364716,-0.029346565
Syndecan interactions,1.8611833e-07,2.0,1.8611833e-07,-0.14149526,0.13269638
Neurexins and neuroligins,2.5441384e-05,2.0,2.5441384e-05,-0.13078266,0.14032128
ECM proteoglycans,3.1615727e-06,2.0,3.1615727e-06,-0.14023314,0.1335947
HIV Infection,1.7745031e-06,3.0,1.7745031e-06,-0.14082152,-0.03445308
Inhibition of TSC complex formation by PKB,2.6605893e-08,2.0,2.6605893e-08,-0.14156292,0.13264821
Nucleobase biosynthesis,1.1633664e-07,3.0,1.1633664e-07,-0.14152487,-0.0349537
Signaling by ERBB4,0.00012704951,5.0,0.00012704951,-0.08768327,-0.3318888
Phase 1 - inactivation of fast Na+ channels,7.9881136e-07,2.0,7.9881136e-07,-0.14123537,0.13288136
Intraflagellar transport,1.1238645e-07,2.0,1.1238645e-07,-0.14152654,0.13267413
Translocation of SLC2A4 (GLUT4) to the plasma membrane,9.747752e-06,2.0,9.747752e-06,-0.13743947,0.13558318
Telomere Maintenance,4.383916e-06,3.0,4.383916e-06,-0.13971467,-0.03366525
RNA Polymerase III Abortive And Retractive Initiation,3.7398146e-05,2.0,3.7398146e-05,-0.12571093,0.14393121
Cytosolic sensors of pathogen-associated DNA ,3.553443e-05,6.0,3.553443e-05,-0.12650147,-0.5271475
TNFR2 non-canonical NF-kB pathway,0.0005761671,4.0,0.0005761671,0.10282015,-0.028664928
Wax biosynthesis,1.8449327e-06,2.0,1.8449327e-06,-0.14079164,0.13319719
tRNA modification in the nucleus and cytosol,8.713784e-05,2.0,8.713784e-05,-0.1046127,0.15894832
Fatty acid metabolism,0.00053872453,7.0,0.00053872453,0.086938046,-0.5428564
Meiotic synapsis,3.3452366e-06,2.0,3.3452366e-06,-0.14015526,0.13365017
Cellular Senescence,0.0010526628,5.0,0.0010526628,0.30493668,-0.0524332
GP1b-IX-V activation signalling,1.693651e-05,2.0,1.693651e-05,-0.1343902,0.13775356
Costimulation by the CD28 family,4.0271763e-05,4.0,4.0271763e-05,-0.12449203,-0.1904592
Cell-cell junction organization,4.8842685e-06,4.0,4.8842685e-06,-0.13950244,-0.2011432
Ca2+ activated K+ channels,1.7903325e-08,2.0,1.7903325e-08,-0.14156662,0.13264559
Post-chaperonin tubulin folding pathway,5.7830857e-06,2.0,5.7830857e-06,-0.13912119,0.13438618
Plasma lipoprotein assembly,6.415396e-08,4.0,6.415396e-08,-0.141547,-0.20259847
Receptor-type tyrosine-protein phosphatases,4.0550545e-05,2.0,4.0550545e-05,-0.12437377,0.14488296
Protein repair,1.9476834e-05,2.0,1.9476834e-05,-0.13331266,0.13852052
Mitochondrial transcription initiation,8.742246e-06,2.0,8.742246e-06,-0.13786599,0.1352796
MAPK1/MAPK3 signaling,0.001044487,3.0,0.001044487,0.3014687,0.2803564
Intracellular oxygen transport,0.0,2.0,0.0,-0.1415742,0.1326402
Regulation of insulin secretion,7.890971e-07,5.0,7.890971e-07,-0.1412395,-0.37000862
Transport of glycerol from adipocytes to the liver by Aquaporins,0.0,2.0,0.0,-0.1415742,0.1326402
Nucleosome assembly,0.00016017885,2.0,0.00016017885,-0.073630705,0.18100043
Glucagon signaling in metabolic regulation,1.0222788e-05,2.0,1.0222788e-05,-0.13723798,0.13572659
SRP-dependent cotranslational protein targeting to membrane,1.6749785e-06,2.0,1.6749785e-06,-0.14086372,0.1331459
Phospholipid metabolism,0.0029510478,3.0,0.0029510478,1.1101798,0.85597384
Regulation of Apoptosis,2.1479414e-06,3.0,2.1479414e-06,-0.1406631,-0.03434032
Intrinsic Pathway of Fibrin Clot Formation,3.4693945e-05,2.0,3.4693945e-05,-0.12685798,0.14311479
IP3 and IP4 transport between cytosol and nucleus,0.0,2.0,0.0,-0.1415742,0.1326402
HSP90 chaperone cycle for steroid hormone receptors (SHR),2.3620152e-07,2.0,2.3620152e-07,-0.14147401,0.1327115
Cellular response to heat stress,0.008049741,4.0,0.008049741,3.2729065,2.2277117
IPs transport between ER lumen and nucleus,0.0,2.0,0.0,-0.1415742,0.1326402
Phase I - Functionalization of compounds,2.8458094e-06,7.0,2.8458094e-06,-0.14036709,-0.70464563
Antimicrobial peptides,1.2164486e-05,4.0,1.2164486e-05,-0.13641436,-0.1989452
mRNA Editing: C to U Conversion,4.0128247e-09,2.0,4.0128247e-09,-0.1415725,0.1326414
Pink/Parkin Mediated Mitophagy,1.8212622e-06,2.0,1.8212622e-06,-0.14080168,0.13319005
Advanced glycosylation endproduct receptor signaling,9.991375e-07,2.0,9.991375e-07,-0.1411504,0.13294184
Latent infection of Homo sapiens with Mycobacterium tuberculosis,0.0,2.0,0.0,-0.1415742,0.1326402
Sphingolipid metabolism,1.2203419e-05,3.0,1.2203419e-05,-0.13639785,-0.031304438
Signal regulatory protein family interactions,4.339273e-07,2.0,4.339273e-07,-0.14139014,0.1327712
Stimuli-sensing channels,8.115145e-08,2.0,8.115145e-08,-0.14153978,0.1326647
G1/S DNA Damage Checkpoints,6.955758e-08,3.0,6.955758e-08,-0.1415447,-0.034967814
Detoxification of Reactive Oxygen Species,1.0817439e-05,2.0,1.0817439e-05,-0.13698575,0.13590613
Netrin-1 signaling,5.97206e-07,5.0,5.97206e-07,-0.14132088,-0.37006652
Diseases associated with O-glycosylation of proteins,2.2870021e-05,10.0,2.2870021e-05,-0.13187337,-1.2014871
Cellular hexose transport,4.769085e-07,2.0,4.769085e-07,-0.14137192,0.13278417
Thrombin signalling through proteinase activated receptors (PARs),0.00013827591,2.0,0.00013827591,-0.08292134,0.17438762
Diseases associated with glycosaminoglycan metabolism,0.0007809585,16.0,0.0007809585,0.18968709,-1.9783837
Integrin cell surface interactions,1.4708834e-05,2.0,1.4708834e-05,-0.13533512,0.137081
Hh mutants abrogate ligand secretion,8.4769e-05,3.0,8.4769e-05,-0.1056175,-0.009395867
TNF signaling,9.847181e-07,5.0,9.847181e-07,-0.14115651,-0.36994952
Acrosome Reaction,0.0,2.0,0.0,-0.1415742,0.1326402
Neurotransmitter release cycle,8.8301204e-07,7.0,8.8301204e-07,-0.14119966,-0.7052382
Prolactin receptor signaling,4.324092e-06,2.0,4.324092e-06,-0.13974003,0.13394569
Class I MHC mediated antigen processing & presentation,6.003377e-06,4.0,6.003377e-06,-0.13902774,-0.20080532
RNA polymerase II transcribes snRNA genes,5.5388846e-06,2.0,5.5388846e-06,-0.13922475,0.13431247
Resolution of Abasic Sites (AP sites),0.00010815678,5.0,0.00010815678,-0.095697045,-0.33759278
"Synthesis, secretion, and deacylation of Ghrelin",5.295734e-07,2.0,5.295734e-07,-0.14134957,0.13280007
Metallothioneins bind metals,0.0,2.0,0.0,-0.1415742,0.1326402
Diseases associated with N-glycosylation of proteins,2.8738004e-10,17.0,2.8738004e-10,-0.14157408,-2.381795
ABC transporters in lipid homeostasis,1.968802e-05,2.0,1.968802e-05,-0.13322309,0.13858427
DDX58/IFIH1-mediated induction of interferon-alpha/beta,0.0041880137,6.0,0.0041880137,1.634867,0.7265441
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),7.827036e-06,2.0,7.827036e-06,-0.1382542,0.13500328
Nucleotide salvage,2.3516372e-05,3.0,2.3516372e-05,-0.1315992,-0.027888898
Lactose synthesis,7.526971e-08,2.0,7.526971e-08,-0.14154229,0.1326629
Signaling by Hippo,2.5697748e-06,2.0,2.5697748e-06,-0.14048417,0.13341604
Activation of Matrix Metalloproteinases,1.2958903e-10,2.0,1.2958903e-10,-0.14157416,0.13264023
SLC transporter disorders,7.005055e-05,73.0,9.595965e-07,-0.14116718,-11.747869
ChREBP activates metabolic gene expression,1.2804378e-07,2.0,1.2804378e-07,-0.14151989,0.13267885
PKMTs methylate histone lysines,6.023773e-06,2.0,6.023773e-06,-0.13901909,0.13445885
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate,1.1081171e-06,2.0,1.1081171e-06,-0.14110416,0.13297474
"ROS, RNS production in phagocytes",1.3453656e-05,2.0,1.3453656e-05,-0.13586754,0.13670203
Metabolism of cofactors,0.0006209088,4.0,0.0006209088,0.121798374,-0.015156776
Signaling by TGF-beta Receptor Complex,3.7198904e-05,4.0,3.7198904e-05,-0.12579544,-0.19138695
Phase 0 - rapid depolarisation,1.0010103e-06,2.0,1.0010103e-06,-0.14114961,0.13294241
mRNA Capping,0.00049544,2.0,0.00049544,0.06857792,0.28222045
S Phase,1.7868238e-07,4.0,1.7868238e-07,-0.14149842,-0.20256388
Complement cascade,0.0009690998,5.0,0.0009690998,0.2694915,-0.07766206
Interaction With The Zona Pellucida,1.5784973e-09,2.0,1.5784973e-09,-0.14157353,0.13264067
Eukaryotic Translation Elongation,2.9341927e-05,2.0,2.9341927e-05,-0.12912816,0.14149892
Mitochondrial protein import,0.00012485786,2.0,0.00012485786,-0.08861291,0.17033653
Physiological factors,3.370983e-06,2.0,3.370983e-06,-0.14014433,0.13365793
Ion transport by P-type ATPases,1.4511471e-05,2.0,1.4511471e-05,-0.13541885,0.1370214
Glucose metabolism,1.5979298e-06,3.0,1.5979298e-06,-0.14089641,-0.034506384
Lysosomal oligosaccharide catabolism,1.0987417e-06,2.0,1.0987417e-06,-0.14110816,0.13297191
Platelet Aggregation (Plug Formation),5.268001e-09,2.0,5.268001e-09,-0.14157197,0.13264178
RAB geranylgeranylation,0.00041002856,2.0,0.00041002856,0.032348726,0.25643355
KSRP (KHSRP) binds and destabilizes mRNA,1.7064389e-08,2.0,1.7064389e-08,-0.14156698,0.13264534
Choline catabolism,7.1201207e-06,2.0,7.1201207e-06,-0.13855405,0.13478985
Integrin alphaIIb beta3 signaling,5.1864423e-05,3.0,5.1864423e-05,-0.11957473,-0.019330224
Metabolism of polyamines,5.961261e-06,7.0,5.961261e-06,-0.13904561,-0.7037051
"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",1.4501195e-06,2.0,1.4501195e-06,-0.1409591,0.13307801
DNA methylation,0.0035376714,2.0,0.0035376714,1.3590095,1.2007127
Signaling by TGF-beta Receptor Complex in Cancer,2.4163696e-06,5.0,2.4163696e-06,-0.14054924,-0.36951733
Interconversion of nucleotide di- and triphosphates,2.1218204e-05,2.0,2.1218204e-05,-0.13257402,0.13904627
ATF6 (ATF6-alpha) activates chaperones,9.0064766e-08,2.0,9.0064766e-08,-0.141536,0.13266739
Intestinal lipid absorption,0.0,2.0,0.0,-0.1415742,0.1326402
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,7.379742e-06,2.0,7.379742e-06,-0.13844392,0.13486823
Cristae formation,1.16207075e-05,2.0,1.16207075e-05,-0.13664502,0.13614865
mRNA decay by 5' to 3' exoribonuclease,5.2901065e-05,2.0,5.2901065e-05,-0.119135015,0.14861177
HuR (ELAVL1) binds and stabilizes mRNA,1.2656775e-05,2.0,1.2656775e-05,-0.13620555,0.13646144
Diseases of carbohydrate metabolism,0.004603109,8.0,0.004603109,1.810939,0.5166091
Nonhomologous End-Joining (NHEJ),0.0016076422,2.0,0.0016076422,0.54034376,0.6180098
Post-translational protein phosphorylation,1.2427921e-05,2.0,1.2427921e-05,-0.13630262,0.13639235
Signal amplification,0.0008091097,4.0,0.0008091097,0.20162806,0.041663714
Neurotransmitter clearance,6.464901e-08,3.0,6.464901e-08,-0.14154679,-0.0349693
Fcgamma receptor (FCGR) dependent phagocytosis,0.0006715609,4.0,0.0006715609,0.1432836,0.00013579502
Reelin signalling pathway,1.193856e-10,2.0,1.193856e-10,-0.14157416,0.13264023
NCAM signaling for neurite out-growth,2.866068e-10,2.0,2.866068e-10,-0.14157408,0.13264027
Synthesis of IPs in the ER lumen,0.0,2.0,0.0,-0.1415742,0.1326402
RNA Polymerase III Transcription Initiation,3.1898755e-05,4.0,3.1898755e-05,-0.12804362,-0.19298713
Influenza Infection,0.0002678769,3.0,0.0002678769,-0.027948134,0.045886956
Inwardly rectifying K+ channels,0.00020495999,5.0,0.00020495999,-0.05463577,-0.30836654
Regulation of gene expression in beta cells,4.194323e-09,2.0,4.194323e-09,-0.14157243,0.13264145
Anchoring of the basal body to the plasma membrane,7.692688e-07,2.0,7.692688e-07,-0.1412479,0.13287245
Kinesins,0.0011890392,2.0,0.0011890392,0.3627838,0.49162772
Sperm Motility And Taxes,1.0684958e-05,2.0,1.0684958e-05,-0.13704194,0.13586614
Mitotic G2-G2/M phases,1.355246e-05,3.0,1.355246e-05,-0.13582562,-0.030897139
Lipid particle organization,2.2755502e-07,2.0,2.2755502e-07,-0.14147767,0.13270889
Diseases associated with visual transduction,9.360376e-07,3.0,9.360376e-07,-0.14117716,-0.03470621
Prostacyclin signalling through prostacyclin receptor,4.6049656e-05,2.0,4.6049656e-05,-0.1220412,0.14654322
Rap1 signalling,1.2659856e-06,2.0,1.2659856e-06,-0.14103721,0.13302241
Nephrin family interactions,1.9646592e-05,2.0,1.9646592e-05,-0.13324066,0.13857177
LGI-ADAM interactions,8.356012e-07,2.0,8.356012e-07,-0.14121976,0.13289246
Surfactant metabolism,1.9656269e-05,2.0,1.9656269e-05,-0.13323656,0.13857469
Sperm:Oocyte Membrane Binding,1.636515e-10,2.0,1.636515e-10,-0.14157413,0.13264024
Mitochondrial ABC transporters,1.4479938e-10,2.0,1.4479938e-10,-0.14157414,0.13264023
PIP3 activates AKT signaling,0.00011947387,5.0,0.00011947387,-0.09089665,-0.334176
"Base-Excision Repair, AP Site Formation",0.00015245854,3.0,0.00015245854,-0.07690545,0.011040546
Metabolism of fat-soluble vitamins,4.625574e-08,4.0,4.625574e-08,-0.1415546,-0.20260385
TYSND1 cleaves peroxisomal proteins,5.4050435e-09,2.0,5.4050435e-09,-0.14157191,0.13264182
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),9.143218e-06,2.0,9.143218e-06,-0.1376959,0.13540065
Homology Directed Repair,0.0017370288,3.0,0.0017370288,0.59522605,0.48944443
Defective Mismatch Repair Associated With PMS2,2.4614632e-08,2.0,2.4614632e-08,-0.14156376,0.13264763
Amine-derived hormones,5.5540665e-09,4.0,5.5540665e-09,-0.14157185,-0.20261616
Amyloid fiber formation,2.7054659e-05,2.0,2.7054659e-05,-0.13009836,0.14080837
trans-Golgi Network Vesicle Budding,1.1287073e-06,2.0,1.1287073e-06,-0.14109544,0.13298096
Electron transport from NADPH to Ferredoxin,1.5867008e-05,2.0,1.5867008e-05,-0.13484386,0.13743067
Transcriptional regulation of white adipocyte differentiation,4.6701118e-07,2.0,4.6701118e-07,-0.14137612,0.1327812
PIWI-interacting RNA (piRNA) biogenesis,0.000342218,2.0,0.000342218,0.0035853363,0.23596059
Invadopodia formation,2.0951778e-05,2.0,2.0951778e-05,-0.13268703,0.13896583
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,0.00021566094,6.0,0.00021566094,-0.050096717,-0.4727648
HDMs demethylate histones,1.2291763e-07,2.0,1.2291763e-07,-0.14152208,0.13267729
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,1.9737915e-06,2.0,1.9737915e-06,-0.14073698,0.13323611
RNA Polymerase I Promoter Clearance,1.7578189e-07,4.0,1.7578189e-07,-0.14149964,-0.20256473
Carboxyterminal post-translational modifications of tubulin,8.27908e-05,2.0,8.27908e-05,-0.10645661,0.15763588
Hedgehog ligand biogenesis,1.2896839e-05,2.0,1.2896839e-05,-0.13610372,0.13653393
Transferrin endocytosis and recycling,9.460741e-05,2.0,9.460741e-05,-0.10144432,0.1612035
Erythrocytes take up oxygen and release carbon dioxide,1.5732803e-07,2.0,1.5732803e-07,-0.14150746,0.1326877
Neurotransmitter receptors and postsynaptic signal transmission,4.19606e-05,6.0,4.19606e-05,-0.12377567,-0.52520734
RNA Polymerase I Transcription Termination,2.1223747e-07,2.0,2.1223747e-07,-0.14148419,0.13270426
Interaction With Cumulus Cells,0.0,2.0,0.0,-0.1415742,0.1326402
AMPK inhibits chREBP transcriptional activation activity,2.5963839e-06,2.0,2.5963839e-06,-0.14047289,0.13342407
DAP12 interactions,0.0003467284,2.0,0.0003467284,0.005498523,0.23732235
Collagen degradation,2.2123245e-06,2.0,2.2123245e-06,-0.1406358,0.13330813
Fructose metabolism,4.661901e-06,3.0,4.661901e-06,-0.13959675,-0.033581324
DNA Replication Pre-Initiation,0.00079204515,3.0,0.00079204515,0.19438975,0.2041407
Branched-chain amino acid catabolism,9.768738e-10,2.0,9.768738e-10,-0.14157379,0.1326405
Intrinsic Pathway for Apoptosis,1.3152035e-05,8.0,1.3152035e-05,-0.13599548,-0.8691631
"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",4.2741294e-07,2.0,4.2741294e-07,-0.1413929,0.13276924
Metabolism of steroids,0.00010416062,6.0,0.00010416062,-0.097392105,-0.5064283
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),1.247264e-07,2.0,1.247264e-07,-0.14152129,0.13267785
Electric Transmission Across Gap Junctions,2.135688e-06,2.0,2.135688e-06,-0.1406683,0.13328499
Ketone body metabolism,4.93666e-07,3.0,4.93666e-07,-0.14136481,-0.03483977
mRNA Editing: A to I Conversion,4.3822197e-07,3.0,4.3822197e-07,-0.14138833,-0.034856517
GPVI-mediated activation cascade,6.3810105e-05,2.0,6.3810105e-05,-0.114507705,0.15190536
Presynaptic depolarization and calcium channel opening,1.5842265e-07,2.0,1.5842265e-07,-0.14150701,0.13268802
TCR signaling,3.2544547e-06,5.0,3.2544547e-06,-0.14019376,-0.36926425
Pre-NOTCH Expression and Processing,1.3272407e-05,4.0,1.3272407e-05,-0.13594443,-0.19861071
Regulation of mitotic cell cycle,4.6916444e-05,2.0,4.6916444e-05,-0.121673524,0.14680493
"Transport of vitamins, nucleosides, and related molecules",1.3671531e-06,5.0,1.3671531e-06,-0.1409943,-0.3698341
Voltage gated Potassium channels,1.1100376e-06,2.0,1.1100376e-06,-0.14110336,0.13297532
MicroRNA (miRNA) biogenesis,0.00071351667,2.0,0.00071351667,0.1610801,0.34806085
RHO GTPase Effectors,0.0018943457,12.0,0.0018943457,0.66195554,-0.9717204
Processing of Intronless Pre-mRNAs,2.4100627e-06,2.0,2.4100627e-06,-0.14055192,0.13336782
